Roche

Drugmakers resist U.K. price goals

admin — Mon, 05 May 2008 06:59:54 -0400

Drug companies are standing their ground in price negotiations with the U.K. government. Pharma is offering to cut the U.K.'s drug bill by roughly half the government's goal, The Daily Telegraph Read more...

Drugmakers fighting for best U.K. deal

admin — Thu, 01 May 2008 06:59:55 -0400

As the U.K. nears a long-term drug-pricing deal with pharma firms, drugmakers are grousing about the fact that the government decided to renegotiate at all. You'll recall that late last year, the Read more...

SPOTLIGHT: NICE rejects Roche drug as too costly

admin — Fri, 25 Apr 2008 06:59:52 -0400

Roche's lung cancer med Tarceva got the goodbye gong from the U.K.'s National Institute for Clinical Excellence, which ruled that the drug wasn't a cost-effective option for treating non-small cell Read more...

Roche, Cipla trade jabs on Tarceva

admin — Mon, 21 Apr 2008 06:59:55 -0400

We turn to India for updates on another cancer-drug battle, this one between Roche's brand-name Tarceva and Cipla's copycat version, Erlocip. A Roche distributor tattled to India's Drug Controller Read more...

Pfizer, Roche suffer as big drugs falter

admin — Thu, 17 Apr 2008 06:59:57 -0400

Today's earnings roundup is a snapshot of pharma's challenges--generic Read more...

Falling dollar, falling drugmaker prices

admin — Tue, 15 Apr 2008 06:59:57 -0400

Is the U.S. drug industry bargain-basement land right now? Analysts say that the low, low dollar means low, low prices for pharma companies. Rivals in Asia and the Eurozone could snap up drug Read more...

FDA probes Roche, Novartis meds

admin — Fri, 11 Apr 2008 06:59:56 -0400

The transplant drug probe is widening. FDA says it's identified 16 cases of an often-fatal neurological disease among patients taking Roche's CellCept drug, used to prevent organ rejection. The Read more...

Roche appeals Mircera injunction

admin — Thu, 10 Apr 2008 06:59:56 -0400

Roche is appealing to a higher power on Mircera. The Swiss drugmaker is appealing a lower court ruling barring Read more...

What did Vasella see in Alcon?

admin — Wed, 09 Apr 2008 06:59:55 -0400

Just why would Novartis pay $11 billion for one-fourth of an eye-care company and promise another $28 Read more...

SPOTLIGHT: Novartis: No more deals, no Roche sale

admin — Tue, 08 Apr 2008 06:59:52 -0400

Two questions raised by yesterday's Novartis-Alcon announcement. Is the Swiss drug maker in the market for Read more...